FDA: Pay To Be Watched (Forbes)
The government wants Big Pharma companies to pay to have the safety of their drugs monitored.

Drugmakers to pay FDA more for tests (The Philadelphia Inquirer)
With a health-care showdown looming in Congress, the pharmaceutical industry agreed to pay 30 percent more for product-safety reviews, including a first-ever fee for scrutiny of its TV ads, officials said yesterday.